2-二苯甲基哌啶
2-二苯甲基哌啶(英語: 或 ,缩写2-DPMP)分子式C18H21N,是一种去甲腎上腺素-多巴胺再吸收抑制劑(NDRI)[1],1950年代由汽巴精化开发[2]。
臨床資料 | |
---|---|
给药途径 | By mouth, nasal and sublingual |
ATC碼 |
|
法律規範狀態 | |
法律規範 |
|
藥物動力學數據 | |
生物利用度 | >90% |
药物代谢 | Liver |
生物半衰期 | 16-20 hours |
识别 | |
| |
CAS号 | 519-74-4 5807-81-8(盐酸盐) |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.007.525 |
化学 | |
化学式 | C18H21N |
摩尔质量 | 251.37 g·mol−1 |
3D模型(JSmol) | |
手性 | Racemic mixture |
| |
|
参考文献
- Ferris RM, Tang FL. . The Journal of Pharmacology and Experimental Therapeutics. September 1979, 210 (3): 422–8. PMID 39160.
- US Patent 2820038 - 2-Diphenyl-Methyl-Piperidine
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.